DB18653InvestigationalCell transplant therapies
ssCART-19 cells consist of autologous anti-CD19 Chimeric Antigen Receptors (CAR)-T cells expressing a short hairpin RNA (shRNA) against interleukin-6 (IL-6).
- Also known as
- autologous anti-CD19 Chimeric Antigen Receptors (CAR)-T cells expressing a short hairpin RNA (shRNA) against interleukin-6 (IL-6) (also termed ssCART-19 cells)
What you can answer from here — as of August 01, 2025
Which companies are running trials of ssCART-19 cells, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account